Antiviral sales fall to three-year lows

From January to November 2023, 79 million packages of antiviral drugs were purchased in Russia for a total amount of 39 billion rubles, they write “Vedomosti” with reference to a report from the marketing agency DSM Group. The report states that this is the lowest figure in the last three years.

In the first 11 months of 2020, residents of the country purchased 102 million packages of antiviral drugs worth 43 billion rubles. In 2021 and 2022 – 93 million and 93.5 million packages for a total amount of 45 billion and 47.7 billion rubles. respectively. In 2023, market participants estimate the reduction in sales of antiviral drugs at approximately 10%, the newspaper reports.

RNC Pharma Development Director Nikolai Bespalov, in a conversation with Vedomosti, explained that the drop in sales occurred due to the absence of record outbreaks of COVID-19 in 2023. At the same time, the number of packages of antiviral drugs sold still exceeds the pre-pandemic level – in 2019 this number amounted to 72 million packages worth RUB 24.5 billion.

The largest drop in sales in 2023 occurred among drugs for the treatment of coronavirus infections. At the same time, in December the number of drugs sold increased by 20% at the Pharmacy 25 chain and by 84% at 36.6 pharmacies. Head of Rospotrebnadzor Anna Popova spokethat for the first time in the last three years in Russia there is a joint rise in the incidence of influenza and COVID-19.

More details in the text “Kommersant” “Coronavirus has become feverish”.

Petr Buzlaev